ARCHIVES

FDA Likely To Change Procedures For Patient Interaction, Official Says

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Robert Cooper, Regional Cancer Center Director, Dead At 59; NCI Critic Epstein Invited to NCAB

April 3, 1992

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

NIH Expands Minority Biomedical Research Training

July 11, 1975

IOM Appoints 17 To National Cancer Policy Board

February 7, 1997

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986